Carnegie acted as joint bookrunner in the directed new share issue of 1,400,000 new shares at a subscription price of SEK 55 per share. The Paxman Scalp Cooling System has been developed by the Paxman family to reduce hair loss in cancer patients undergoing chemotherapy.
December 2021.
Healthcare
Directed new share issue in Paxman AB — SEK 77 million
December 2021